Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1992-12-04
1994-09-13
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424 2, 424 4, 424491, 424492, 424493, 424494, 424496, 424497, 424498, 424 5, 514970, 514971, 514975, A61K 914, A61K 954
Patent
active
053467027
ABSTRACT:
This invention discloses a composition comprised of nanoparticles having a surface modifier adsorbed on the surface thereof and a non-ionic cloud point modifier associated therewith, which cloud point modifier is present in an amount-sufficient to increase the cloud point of the surface modifier. A preferred surface modifier is a poloxamine such as Tetronic 908, and preferred non-ionic cloud point modifiers include polyethylene glycol, propylene glycol, ethanol, hydroxypropylcyclodextrin and/or glycerol. This invention further discloses a method of making nanoparticles having a surface modifier adsorbed on the surface and a non-ionic cloud point modifier associated therewith, comprised of contacting said nanoparticles with the cloud point modifier for a time and under conditions sufficient to increase the cloud point of the surface modifier.
REFERENCES:
patent: 5145684 (1991-01-01), Liversidge et al.
Na George C.
Rajagopalan Natarajan
Davis William J.
Page Thurman K.
Spear James M.
Sterling Winthrop Inc.
LandOfFree
Use of non-ionic cloud point modifiers to minimize nanoparticle does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of non-ionic cloud point modifiers to minimize nanoparticle , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of non-ionic cloud point modifiers to minimize nanoparticle will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1118916